Početna › Ulcerativni kolitis › Illinois › Chicago
Kliničke studije za Ulcerativni kolitis u gradu Chicago, IL
15 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu Chicago i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
U tijeku regrutacijaFaza 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
U tijeku regrutacijaFaza 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
U tijeku regrutacijaFaza 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
U tijeku regrutacijaFaza 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
U tijeku regrutacija
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
U tijeku regrutacijaOpažajna studija
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
U tijeku regrutacijaFaza 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
U tijeku regrutacijaFaza 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
U tijeku regrutacija
- University of Chicago, Chicago
Studije za Ulcerativni kolitis u drugim gradovima
- New York City, NY23 studija
- Orlando, FL22 studija
- Miami, FL21 studija
- Houston, TX17 studija
- San Antonio, TX16 studija
- Tacoma, WA15 studija
- San Diego, CA15 studija
- Tyler, TX14 studija
- Colorado Springs, CO14 studija
- Los Angeles, CA13 studija
- St. Louis, MO13 studija
- Washington, DC12 studija
Ostale studije u gradu Chicago
- Nemikrocelularni karcinom pluća61 studija
- Rak dojke58 studija
- Rak (sve vrste)51 studija
- Metastatski karcinom45 studija
- Rak prostate45 studija
- Debljina41 studija
- Rak pluća41 studija
- Rak jajnika36 studija
- Moždani udar34 studija
- Kolorektalni rak33 studija
- Srčano zatajenje31 studija
- Prekomjerna tjelesna masa28 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.